STAGE III PROSTATE CANCER AJCC V7
Clinical trials for STAGE III PROSTATE CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE III PROSTATE CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE III PROSTATE CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to stop prostate cancer from spreading
Disease control OngoingThis study tests whether adding an experimental drug (MK-2206) to standard hormone therapy (bicalutamide) works better than hormone therapy alone for men with prostate cancer whose PSA levels are rising after initial treatment. About 108 men will take part. The main goal is to se…
Matched conditions: STAGE III PROSTATE CANCER AJCC V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 11:31 UTC
-
Experimental combo targets Cancer's Self-Eating process
Disease control OngoingThis early-phase trial tests the safety and best dose of combining two drugs—MK-2206 and hydroxychloroquine—in people with advanced solid tumors, melanoma, or prostate or kidney cancer. The goal is to see if blocking a process called autophagy can help kill more cancer cells. Abo…
Matched conditions: STAGE III PROSTATE CANCER AJCC V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 11:28 UTC